Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04433650 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pictorial Support in Person-centred Care for Children (PicPecc)

Study acronym: PicPecc
StatusCompleted
PhaseNot applicable
Started2021-03-01
View on ClinicalTrials.gov ↗

Amendment history

2026-09-08
notable
Study Status, Study Design, Contacts/Locations v6
Trial completed
Final enrollment: 29 participants (planned 40)
Primary completion confirmed: March 2025 (last estimated December 2026)
Primary completion dateestimated 2026-12-31→confirmed 2025-03-31
Completion dateestimated 2026-12-31→confirmed 2025-03-31
Start date2021-04-01→2021-03-01
Enrollment targetestimated 40→confirmed 29
Study sitesdetails revised at 1 of 1 site
2025-04-03
minor
Study Status v5
Primary completion date2024-12-31→2026-12-31
Completion date2025-06-30→2026-12-31
2024-02-26
minor
Study Status v4
Primary completion date2023-06-30→2024-12-31
Completion date2023-12-31→2025-06-30
2022-08-13
minor
Study Status v3
Re-verified, no change to tracked fields
2021-05-20
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2021-03-01→confirmed 2021-04-01
Study sitesdetails revised at 1 of 1 site
2021-02-01
minor
Study Status, References v1
Primary completion date2022-12-31→2023-06-30
Completion date2022-12-31→2023-12-31
Start date2020-10-01→2021-03-01
2020-06-14
minor
Original filing
Introduction: Person-centred care is based on the assumption that every person has resources that should be used in the care situation. In order for this to happen the patient has to be able to effectively communicate his/her symptoms. This protocol describes the analysis of a digital picture-based tool for communication support for children with cancer aged 5-17 years, who undergo high-dose methotrexate treatment. The advantage of a non-linguistic based platform, beside the expected clinical outcomes, is that it can be used in multiple national studies with minimal translation. Methods and analysis: Two studies will be conducted in a hybrid design, i.e., a crossover design will be used for the intervention (effects), and a mixed-methods design will be used for the process evaluation. Qualitative interviews will be carried out with children with cancer, their legal guardians and case-related healthcare professionals as part of the process evaluation. The interviews will address the experiences of the intervention and frequency of use from the child's perspective. Interview transcripts will be analyzed qualitative descriptively. The digital communication tool will collect child self-reports of symptoms/emotions. The children will be monitored for biomarkers of stress and pain (neuropeptides, neurosteroids and peripheral steroids) in venous blood samples, in-app estimation levels for the children, drug consumption. Person-centeredness will be evaluated with the questionnaire Visual CARE Measure. Ethics: Ethical approval was obtained from the Swedish Ethical Review Authority (ref 2019-02392; 2020-02601).
Trial Details
NCT Number NCT04433650
Lead Sponsor Göteborg University
Collaborators: Swedish Childhood Cancer Fund
Conditions Childhood Cancer, Communication, Symptoms and Signs
Enrollment 29 participants
Start Date 2021-03-01
Primary Completion 2025-03-31 (estimated)
Study Completion 2025-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-09-09